Earth Science Tech, Inc.

ETST

US2703111037

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 03:29:55 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0625 ^USD	+5.93%		+13.64%	-10.33%

Apr. 15	Mario G. Tabraue Relinquish His Role as President of Earth Science Tech, Inc	CI
Mar. 05	Earth Science Tech, Inc. Announces CFO Changes	CI

Earth Science Tech, Inc. announces an Equity Buyback for $5 million worth of its shares.

January 29, 2024 at 09:06 am EST

Earth Science Tech, Inc. (OTCPK:ETST) announces a share repurchase program. Under the program, the company will repurchase up to $5 million worth of its shares. The repurchase program expires December 31, 2025.

Latest news about Earth Science Tech, Inc.

Mario G. Tabraue Relinquish His Role as President of Earth Science Tech, Inc	Apr. 15	CI
Earth Science Tech, Inc. Announces CFO Changes	Mar. 05	CI
Earth Science Tech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 20	CI
Earth Science Tech, Inc. announces an Equity Buyback for $5 million worth of its shares.	Jan. 29	CI
Earth Science Tech, Inc. authorizes a Buyback Plan.	Jan. 28	CI
Earth Science Tech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 13	CI
Earth Science Tech, Inc. Announces Board Appointments	Nov. 08	CI
Earth Science Tech, Inc. Announces the Resignation Nickolas S. Tabraue as Chief Compliance Officer	23-08-16	CI
Earth Science Tech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-27	CI
Earth Science Tech, Inc. Announces CFO Changes	23-07-17	CI
Earth Science Tech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-20	CI
Earth Science Tech, Inc. Auditor Raises 'Going Concern' Doubt	23-06-19	CI
Insider Buy: Earth Science Tech	23-06-16	MT
Insider Buy: Earth Science Tech	23-06-07	MT
Earth Science Tech, Inc. Announces Executive Changes	23-02-14	CI
Earth Science Tech, Inc. Announces Board Changes	23-02-14	CI
Earth Science Tech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-10	CI
Earth Science Tech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Earth Science Tech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-15	CI
Earth Science Tech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-15	CI
Earth Science Tech, Inc. Auditor Raises 'Going Concern' Doubt	22-07-14	CI
Earth Science Tech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-04-28	CI
Earth Science Tech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-22	CI
Earth Science Tech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021	21-09-28	CI
Earth Science Tech, Inc. Auditor Raises 'Going Concern' Doubt	21-09-27	CI

Chart Earth Science Tech, Inc.

Duration

Period

More charts

Company Profile

Earth Science Tech, Inc. is a holding company in the compounding pharmaceuticals and telemedicine sectors, through its wholly owned subsidiaries, RxCompoundStore.com, LLC. (RxCompound), Peaks Curative, LLC. (Peaks), and Earth Science Foundation, Inc. (ESF). RxCompound is a complete compounding pharmacy. RxCompound is licensed to fulfill prescriptions in the states of Florida, New York, New Jersey, Delaware, Pennsylvania, Rhode Island, Nevada, Colorado, and Arizona. Peaks is a telemedicine referral site focused on menâs health. Peaks orders are fulfilled by RxCompound. Patients who order Peaks via monthly subscription receive their refills automatically. Peaks is focused on menâs health, and, more specifically, ED. ESF accepts grants and donations to help those in need of assistance in paying for prescriptions.

Sector

Pharmaceuticals

Calendar

2024-07-25 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EARTH SCIENCE TECH, INC.	-10.33%	19.37M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B